BMRA
Biomerica, Inc.
Price Chart
Latest Quote
$1.94
-0.03 (-1.60%)
Current Price
| Previous Close | $1.97 |
| Open | $1.96 |
| Day High | $2.00 |
| Day Low | $1.94 |
| Volume | 11,280 |
Stock Information
| Shares Outstanding | 3.09M |
| Total Debt | $193K |
| Cash Equivalents | $1.34M |
| Revenue | $4.33M |
| Net Income | $-4.17M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $5.99M |
| EPS (TTM) | $-1.61 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.82M |
| Sales | $4.33M |
| Income | $-4.17M |
| Book/sh | $1.09 |
| Cash/sh | $0.43 |
| Employees | 53 |
Financial Ratios
| Quick Ratio | 1.46 |
| Current Ratio | 2.64 |
| Debt/Eq | 5.82 |
Returns & Margins
| ROA | -54.58% |
| ROE | -94.32% |
| Gross Margin | 4.37% |
| Operating Margin | -131.51% |
| Profit Margin | -96.46% |
Ownership
| Insider Ownership | 15.24% |
| Institutional Ownership | 3.62% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 4.97 |
| P/S | 1.38 |
| P/B | 1.77 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $2.19 |
| SMA50 | $2.20 |
| SMA200 | $2.42 |
| RSI | 19.96 |
| ATR | 0.1373 |
| Shares Float | 2.77M |
| Short Float | 2.92% |
| Short Ratio | 4.26 |
| Volatility | 0.29 |
| Rel Volume | 0.57 |
Performance History
| Week | -7.25% |
| Month | -18.55% |
| Quarter | -6.80% |
| 6 Months | -18.21% |
| YTD | -23.38% |
| Year | -40.54% |
| 3 Years | -83.85% |
| 5 Years | -94.05% |
| 10 Years | -84.06% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.94 | 11,280 |
| 2026-06-17 | $1.97 | 30,700 |
| 2026-06-16 | $1.93 | 26,300 |
| 2026-06-15 | $2.00 | 23,500 |
| 2026-06-12 | $2.05 | 12,000 |
| 2026-06-11 | $2.09 | 14,400 |
| 2026-06-10 | $2.02 | 9,500 |
| 2026-06-09 | $2.05 | 43,700 |
| 2026-06-08 | $2.07 | 18,600 |
| 2026-06-05 | $2.12 | 15,300 |
| 2026-06-04 | $2.15 | 11,700 |
| 2026-06-03 | $2.11 | 10,000 |
| 2026-06-02 | $2.18 | 47,600 |
| 2026-06-01 | $2.36 | 13,100 |
| 2026-05-29 | $2.39 | 6,900 |
| 2026-05-28 | $2.43 | 56,300 |
| 2026-05-27 | $2.46 | 9,500 |
| 2026-05-26 | $2.47 | 17,400 |
| 2026-05-22 | $2.49 | 8,500 |
| 2026-05-21 | $2.44 | 12,100 |
| 2026-05-20 | $2.35 | 9,200 |
| 2026-05-19 | $2.38 | 19,000 |
| 2026-05-18 | $2.25 | 8,400 |
About Biomerica, Inc.
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. The company has strategic partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs for launching the inFoods platform in Canada. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $4,813,000 | $4,804,000 | $4,893,000 | $15,894,000 |
| Cost Of Revenue | $4,813,000 | $4,804,000 | $4,893,000 | $15,894,000 |
| Total Revenue | $5,311,000 | $5,415,000 | $5,339,000 | $18,871,000 |
| Operating Revenue | $5,311,000 | $5,415,000 | $5,339,000 | $18,871,000 |
| Expenses | ||||
| Total Expenses | $10,448,000 | $11,782,000 | $12,562,000 | $23,405,000 |
| Net Non Operating Interest Income Expense | $165,000 | $431,000 | $133,000 | $27,000 |
| Operating Expense | $5,635,000 | $6,978,000 | $7,669,000 | $7,511,000 |
| Other Income Expense | - | - | $1,000 | - |
| Other Non Operating Income Expenses | - | - | $1,000 | - |
| Interest Expense | - | - | - | $0 |
| Interest Expense Non Operating | - | - | - | $0 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-4,973,000 | $-5,978,000 | $-7,140,000 | $-4,531,000 |
| Net Interest Income | $165,000 | $431,000 | $133,000 | $27,000 |
| Interest Income | $165,000 | $431,000 | $133,000 | $27,000 |
| Normalized Income | $-4,973,000 | $-5,978,000 | $-7,140,000 | $-4,531,000 |
| Net Income From Continuing And Discontinued Operation | $-4,973,000 | $-5,978,000 | $-7,140,000 | $-4,531,000 |
| Total Operating Income As Reported | $-5,137,000 | $-6,367,000 | $-7,223,000 | $-4,534,000 |
| Net Income Common Stockholders | $-4,973,000 | $-5,978,000 | $-7,140,000 | $-4,531,000 |
| Net Income | $-4,973,000 | $-5,978,000 | $-7,140,000 | $-4,531,000 |
| Net Income Including Noncontrolling Interests | $-4,973,000 | $-5,978,000 | $-7,140,000 | $-4,531,000 |
| Net Income Continuous Operations | $-4,973,000 | $-5,978,000 | $-7,140,000 | $-4,531,000 |
| Pretax Income | $-4,972,000 | $-5,936,000 | $-7,089,000 | $-4,507,000 |
| Interest Income Non Operating | $165,000 | $431,000 | $133,000 | $27,000 |
| Operating Income | $-5,137,000 | $-6,367,000 | $-7,223,000 | $-4,534,000 |
| Gross Profit | $498,000 | $611,000 | $446,000 | $2,977,000 |
| Per Share | ||||
| Diluted EPS | $-2.16 | $-2.84 | $-4.00 | $-2.88 |
| Basic EPS | $-2.16 | $-2.84 | $-4.00 | $-2.88 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-4,737,000 | $-5,993,000 | $-6,872,000 | $-3,939,000 |
| Reconciled Depreciation | $400,000 | $374,000 | $351,000 | $595,000 |
| EBITDA (Bullshit earnings) | $-4,737,000 | $-5,993,000 | $-6,872,000 | $-3,939,000 |
| EBIT | $-5,137,000 | $-6,367,000 | $-7,223,000 | $-4,534,000 |
| Diluted Average Shares | $2,297,057 | $2,103,154 | $1,769,283 | $1,584,155 |
| Basic Average Shares | $2,297,057 | $2,103,154 | $1,769,283 | $1,584,155 |
| Diluted NI Availto Com Stockholders | $-4,973,000 | $-5,978,000 | $-7,140,000 | $-4,531,000 |
| Tax Provision | $1,000 | $42,000 | $51,000 | $24,000 |
| Research And Development | $1,023,000 | $1,491,000 | $1,584,000 | $1,812,000 |
| Selling General And Administration | $4,612,000 | $5,487,000 | $6,085,000 | $5,699,000 |
| Total Unusual Items | - | - | - | - |
| Total Unusual Items Excluding Goodwill | - | - | - | - |
| Gain On Sale Of Security | - | - | - | - |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,877,000 | $6,379,000 | $11,559,000 | $8,155,000 |
| Total Assets | $5,945,000 | $9,254,000 | $14,454,000 | $11,374,000 |
| Total Non Current Assets | $1,070,000 | $1,523,000 | $1,657,000 | $1,947,000 |
| Other Non Current Assets | $113,000 | $203,000 | $79,000 | $96,000 |
| Investmentin Financial Assets | $165,000 | $165,000 | $165,000 | $165,000 |
| Goodwill And Other Intangible Assets | $228,000 | $212,000 | $165,000 | $170,000 |
| Other Intangible Assets | $228,000 | $212,000 | $165,000 | $170,000 |
| Current Assets | $4,875,000 | $7,731,000 | $12,797,000 | $9,427,000 |
| Other Current Assets | $255,000 | $238,000 | $300,000 | $320,000 |
| Inventory | $1,490,000 | $2,376,000 | $2,056,000 | $2,416,000 |
| Receivables | $731,000 | $947,000 | $722,000 | $774,000 |
| Accounts Receivable | $731,000 | $947,000 | $722,000 | $774,000 |
| Allowance For Doubtful Accounts Receivable | $-26,000 | $-19,000 | $-29,000 | $-153,000 |
| Gross Accounts Receivable | $757,000 | $966,000 | $751,000 | $927,000 |
| Cash Cash Equivalents And Short Term Investments | $2,399,000 | $4,170,000 | $9,719,000 | $5,917,000 |
| Cash And Cash Equivalents | $2,399,000 | $4,170,000 | $9,719,000 | $5,917,000 |
| Prepaid Assets | - | $238,000 | $300,000 | $320,283 |
| Debt | ||||
| Total Debt | $458,000 | $785,000 | $1,082,000 | $1,379,000 |
| Long Term Debt And Capital Lease Obligation | $100,000 | $459,000 | $785,000 | $1,038,000 |
| Current Debt And Capital Lease Obligation | $358,000 | $326,000 | $297,000 | $341,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,840,000 | $2,663,000 | $2,730,000 | $3,049,000 |
| Total Non Current Liabilities Net Minority Interest | $100,000 | $459,000 | $785,000 | $1,038,000 |
| Current Liabilities | $1,740,000 | $2,204,000 | $1,945,000 | $2,011,000 |
| Current Deferred Liabilities | $55,000 | $85,000 | $60,000 | $51,000 |
| Payables And Accrued Expenses | $672,000 | $1,138,000 | $892,000 | $972,000 |
| Payables | $295,000 | $560,000 | $344,000 | $736,000 |
| Accounts Payable | $295,000 | $560,000 | $344,000 | $736,000 |
| Other Current Liabilities | - | - | - | $372 |
| Equity | ||||
| Common Stock Equity | $4,105,000 | $6,591,000 | $11,724,000 | $8,325,000 |
| Total Equity Gross Minority Interest | $4,105,000 | $6,591,000 | $11,724,000 | $8,325,000 |
| Stockholders Equity | $4,105,000 | $6,591,000 | $11,724,000 | $8,325,000 |
| Gains Losses Not Affecting Retained Earnings | $-105,000 | $-102,000 | $-110,000 | $-74,000 |
| Other Equity Adjustments | $-105,000 | $-102,000 | $-110,000 | $-74,000 |
| Retained Earnings | $-53,168,000 | $-48,195,000 | $-42,217,000 | $-35,077,000 |
| Other | ||||
| Ordinary Shares Number | $2,546,216 | $2,102,705 | $2,102,705 | $1,608,490 |
| Share Issued | $2,546,216 | $2,102,705 | $2,102,705 | $1,608,490 |
| Tangible Book Value | $3,877,000 | $6,379,000 | $11,559,000 | $8,155,000 |
| Invested Capital | $4,105,000 | $6,591,000 | $11,724,000 | $8,325,000 |
| Working Capital | $3,135,000 | $5,527,000 | $10,852,000 | $7,416,000 |
| Capital Lease Obligations | $458,000 | $785,000 | $1,082,000 | $1,379,000 |
| Total Capitalization | $4,105,000 | $6,591,000 | $11,724,000 | $8,325,000 |
| Additional Paid In Capital | $57,175,000 | $54,720,000 | $52,705,000 | $42,447,000 |
| Capital Stock | $203,000 | $168,000 | $1,346,000 | $1,029,000 |
| Common Stock | $203,000 | $168,000 | $1,346,000 | $1,029,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $100,000 | $459,000 | $785,000 | $1,038,000 |
| Current Deferred Revenue | $55,000 | $85,000 | $60,000 | $51,000 |
| Current Capital Lease Obligation | $358,000 | $326,000 | $297,000 | $341,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $655,000 | $655,000 | $696,000 | $647,000 |
| Current Accrued Expenses | $377,000 | $578,000 | $548,000 | $236,000 |
| Investments And Advances | $165,000 | $165,000 | $165,000 | $165,000 |
| Net PPE | $564,000 | $943,000 | $1,248,000 | $1,516,000 |
| Accumulated Depreciation | $-2,683,000 | $-2,304,000 | $-1,948,000 | $-2,030,000 |
| Gross PPE | $3,247,000 | $3,247,000 | $3,196,000 | $3,546,000 |
| Other Properties | $3,036,000 | $3,036,000 | $2,985,000 | $3,319,000 |
| Machinery Furniture Equipment | $211,000 | $211,000 | $211,000 | $227,000 |
| Inventories Adjustments Allowances | $-471,000 | $-467,000 | $-672,000 | $-846,000 |
| Finished Goods | $147,000 | $179,000 | $182,000 | $782,000 |
| Work In Process | $743,000 | $1,145,000 | $869,000 | $763,000 |
| Raw Materials | $1,071,000 | $1,519,000 | $1,677,000 | $1,717,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-3,878,000 | $-5,476,000 | $-5,552,000 | $-649,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-3,841,000 | $-5,361,000 | $-5,474,000 | $-479,000 |
| Cash Flow From Continuing Operating Activities | $-3,841,000 | $-5,361,000 | $-5,474,000 | $-479,000 |
| Operating Gains Losses | - | - | - | $53,000 |
| Investing Activities | ||||
| Capital Expenditure | $-37,000 | $-115,000 | $-78,000 | $-170,000 |
| Investing Cash Flow | $-37,000 | $-115,000 | $-78,000 | $-170,000 |
| Cash Flow From Continuing Investing Activities | $-37,000 | $-115,000 | $-78,000 | $-170,000 |
| Capital Expenditure Reported | $-37,000 | $-64,000 | $-14,000 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $2,143,000 | $0 | $10,014,000 | $2,402,000 |
| Financing Cash Flow | $2,111,000 | $-81,000 | $9,390,000 | $2,394,000 |
| Cash Flow From Continuing Financing Activities | $2,111,000 | $-81,000 | $9,390,000 | $2,394,000 |
| Net Other Financing Charges | $-47,000 | $-81,000 | $-705,000 | $-85,000 |
| Net Common Stock Issuance | $2,143,000 | $0 | $10,014,000 | $2,402,000 |
| Common Stock Issuance | $2,143,000 | $0 | $10,014,000 | $2,402,000 |
| Repurchase Of Capital Stock | - | $0 | $-705,000 | $-85,000 |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| Income Tax Paid Supplemental Data | $10,000 | $41,000 | $51,000 | $24,000 |
| End Cash Position | $2,400,000 | $4,170,000 | $9,719,000 | $5,917,000 |
| Beginning Cash Position | $4,170,000 | $9,719,000 | $5,917,000 | $4,199,000 |
| Effect Of Exchange Rate Changes | $-3,000 | $8,000 | $-36,000 | $-26,000 |
| Changes In Cash | $-1,767,000 | $-5,557,000 | $3,838,000 | $1,744,000 |
| Proceeds From Stock Option Exercised | $15,000 | $0 | $81,000 | $77,000 |
| Net PPE Purchase And Sale | $0 | $-51,000 | $-64,000 | $-57,000 |
| Purchase Of PPE | $0 | $-51,000 | $-64,000 | $-57,000 |
| Change In Working Capital | $268,000 | $-389,000 | $304,000 | $3,600,000 |
| Change In Other Working Capital | $-22,000 | $15,000 | $351,000 | $51,000 |
| Change In Other Current Liabilities | $-327,000 | $-297,000 | $-297,000 | $-244,000 |
| Change In Other Current Assets | $8,000 | $-44,000 | $18,000 | $169,000 |
| Change In Payables And Accrued Expense | $-465,000 | $205,000 | $-31,000 | $647,000 |
| Change In Accrued Expense | $1,000 | $-41,000 | $49,000 | $258,000 |
| Change In Payable | $-466,000 | $246,000 | $-80,000 | $389,000 |
| Change In Account Payable | $-466,000 | $246,000 | $-80,000 | $389,000 |
| Change In Prepaid Assets | $-17,000 | $62,000 | $20,000 | $50,000 |
| Change In Inventory | $882,000 | $-115,000 | $534,000 | $1,562,000 |
| Change In Receivables | $209,000 | $-215,000 | $-291,000 | $1,365,000 |
| Changes In Account Receivables | $209,000 | $-215,000 | $-291,000 | $1,365,000 |
| Stock Based Compensation | $460,000 | $837,000 | $1,185,000 | $1,260,000 |
| Provisionand Write Offof Assets | $4,000 | $-205,000 | $-174,000 | $-1,456,000 |
| Depreciation Amortization Depletion | $400,000 | $374,000 | $351,000 | $595,000 |
| Depreciation And Amortization | $400,000 | $374,000 | $351,000 | $595,000 |
| Depreciation | $400,000 | $374,000 | $351,000 | $595,000 |
| Net Income From Continuing Operations | $-4,973,000 | $-5,978,000 | $-7,140,000 | $-4,531,000 |
| Common Stock Payments | - | $0 | $-705,000 | $-85,000 |
| Net Intangibles Purchase And Sale | - | - | $-14,000 | $-113,000 |
| Purchase Of Intangibles | - | - | $-14,000 | $-113,000 |
| Gain Loss On Sale Of PPE | - | - | $0 | $53,000 |
| Interest Paid Supplemental Data | - | - | - | - |
Fetched: 2026-06-18